_id
690f3504ccc777a4e85d16b2
Ticker
BHIC
Name
BHIC
Exchange
PINK
Address
2722 South West Temple, Salt Lake City, UT, United States, 84115
Country
USA
Sector
Healthcare
Industry
Pharmaceutical Retailers
Currency
USD
Website
-
Description
BioScience Health Innovations, Inc. distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses in the United States. The company markets Be On-Guard Mouth Spray and Nasal Spray; EZ Safer Surface Cleaner; Be On-Guard brain fog support; Active Daily Health Defence 365 for maximum strength brain support; NeuroPro Plus, a patent pending combination of pharmaceutical grade methylene blue and vitamin; TBI-365 to elevate brain health and wellness with pharmaceutical grade methylene blue, glucine, nac and niacinamide; and Metabolism+ to enhance metabolism. It sells its products through Amazon platform; wholesales through online platform; private label sales; and direct sales. The company was formerly known as Nowtransit Inc and changed its name to BioScience Health Innovations, Inc. on February 21, 2025. BioScience Health Innovations, Inc. is based in Salt Lake City, Utah.
Last Close
1
Volume
293
Current Price
4
Change
0
Last Updated
2026-01-20T16:31:35.494Z
Image
-
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
1757463
Cost Of Revenue
682985
Gross Profit
1074478
Operating Expenses
1299759
Operating Income
457704
Interest Expense
-
Pretax Income
457704
Net Income
457704
Eps
0.04168883387504662
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
26.04345013237832
Total Other Income Expense Net
-
Cash
1299407
Short Term Investments
-
Receivables
390013
Inventories
248519
Total Current Assets
1985273
Property Plant Equipment
-
Total Assets
2057374
Payables
16636
Short Term Debt
-
Long Term Debt
-
Total Liabilities
337632
Equity
1719742
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-172694
Cash From Operations
285010
Capital Expenditures
16064
Cash From Investing
-
Cash From Financing
2119
Net Change In Cash
271065
Cf_currency_symbol
USD
PE
-
PB
25.536516523990226
ROE
26.61468987790029
ROA
22.24700030232714
FCF
268946
Fcf Percent
0.15303081771849536
Piotroski FScore
3
Health Score
81
Deep Value Investing Score
7
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
10
Garp Investing Score
10
Growth Investing Score
7
Momentum Investing Score
8
Net Net Investing Score
3.5
Quality Investing Score
8.5
Value Investing Score
9.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1757463
Quarters > 0 > income Statement > cost Of Revenue
682985
Quarters > 0 > income Statement > gross Profit
1074478
Quarters > 0 > income Statement > operating Expenses
1299759
Quarters > 0 > income Statement > operating Income
457704
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
457704
Quarters > 0 > income Statement > net Income
457704
Quarters > 0 > income Statement > eps
0.04168883387504662
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
10979055
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
26.04345013237832
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1299407
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
390013
Quarters > 0 > balance Sheet > inventories
248519
Quarters > 0 > balance Sheet > total Current Assets
1985273
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
2057374
Quarters > 0 > balance Sheet > payables
16636
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
337632
Quarters > 0 > balance Sheet > equity
1719742
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
457704
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-172694
Quarters > 0 > cash Flow > cash From Operations
285010
Quarters > 0 > cash Flow > capital Expenditures
16064
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2119
Quarters > 0 > cash Flow > net Change In Cash
271065
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.04168883387504662
Quarters > 0 > ratios > PB
25.536516523990226
Quarters > 0 > ratios > ROE
26.61468987790029
Quarters > 0 > ratios > ROA
22.24700030232714
Quarters > 0 > ratios > FCF
268946
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.15303081771849536
Quarters > 0 > health Score
81
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
1227070
Quarters > 1 > income Statement > cost Of Revenue
330925
Quarters > 1 > income Statement > gross Profit
896145
Quarters > 1 > income Statement > operating Expenses
800272
Quarters > 1 > income Statement > operating Income
426798
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
426798
Quarters > 1 > income Statement > net Income
426798
Quarters > 1 > income Statement > eps
0.03887383750240799
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
10979055
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
34.78187878442143
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1028342
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
93449
Quarters > 1 > balance Sheet > inventories
215696
Quarters > 1 > balance Sheet > total Current Assets
1338922
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
1394959
Quarters > 1 > balance Sheet > payables
16415
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
132921
Quarters > 1 > balance Sheet > equity
1262038
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
426798
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-98489
Quarters > 1 > cash Flow > cash From Operations
328309
Quarters > 1 > cash Flow > capital Expenditures
30000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
67516
Quarters > 1 > cash Flow > net Change In Cash
365825
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.03887383750240799
Quarters > 1 > ratios > PB
34.79785870156049
Quarters > 1 > ratios > ROE
33.81815761490542
Quarters > 1 > ratios > ROA
30.59573793925126
Quarters > 1 > ratios > FCF
298309
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.24310675022614847
Quarters > 1 > health Score
85
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
610222
Quarters > 2 > income Statement > cost Of Revenue
271213
Quarters > 2 > income Statement > gross Profit
339009
Quarters > 2 > income Statement > operating Expenses
600265
Quarters > 2 > income Statement > operating Income
9957
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
9957
Quarters > 2 > income Statement > net Income
9957
Quarters > 2 > income Statement > eps
0.000906908654706621
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
10979055
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
1.6317012497091221
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
662517
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
100285
Quarters > 2 > balance Sheet > inventories
58319
Quarters > 2 > balance Sheet > total Current Assets
847751
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
873788
Quarters > 2 > balance Sheet > payables
8226
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
38548
Quarters > 2 > balance Sheet > equity
835240
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
9957
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-60262
Quarters > 2 > cash Flow > cash From Operations
-50305
Quarters > 2 > cash Flow > capital Expenditures
19000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
398602
Quarters > 2 > cash Flow > net Change In Cash
329297
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.000906908654706621
Quarters > 2 > ratios > PB
52.57916287534122
Quarters > 2 > ratios > ROE
1.1921124467219002
Quarters > 2 > ratios > ROA
1.1395212568723765
Quarters > 2 > ratios > FCF
-69305
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.11357342082061939
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
572973
Quarters > 3 > income Statement > cost Of Revenue
148233
Quarters > 3 > income Statement > gross Profit
424740
Quarters > 3 > income Statement > operating Expenses
516771
Quarters > 3 > income Statement > operating Income
56202
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
56202
Quarters > 3 > income Statement > net Income
56202
Quarters > 3 > income Statement > eps
0.00534033697087292
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
10524055
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
9.808839159960417
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
333220
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
31913
Quarters > 3 > balance Sheet > inventories
42225
Quarters > 3 > balance Sheet > total Current Assets
415830
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
415830
Quarters > 3 > balance Sheet > payables
8447
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
45547
Quarters > 3 > balance Sheet > equity
370283
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
56202
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-3969
Quarters > 3 > cash Flow > cash From Operations
52233
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
144102
Quarters > 3 > cash Flow > net Change In Cash
189298
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.00534033697087292
Quarters > 3 > ratios > PB
113.6866126719293
Quarters > 3 > ratios > ROE
15.178120518630344
Quarters > 3 > ratios > ROA
13.515619363682275
Quarters > 3 > ratios > FCF
52233
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.09116136362446398
Quarters > 3 > health Score
71
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1844966
Annuals > 0 > income Statement > cost Of Revenue
536078
Annuals > 0 > income Statement > gross Profit
1308888
Annuals > 0 > income Statement > operating Expenses
1757966
Annuals > 0 > income Statement > operating Income
87000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
87000
Annuals > 0 > income Statement > net Income
87000
Annuals > 0 > income Statement > eps
0.00792417926679482
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
10979055
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
4.715534053202065
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
662517
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
100285
Annuals > 0 > balance Sheet > inventories
58319
Annuals > 0 > balance Sheet > total Current Assets
847751
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
873788
Annuals > 0 > balance Sheet > payables
8226
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
38548
Annuals > 0 > balance Sheet > equity
835240
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
87000
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-63812
Annuals > 0 > cash Flow > cash From Operations
23188
Annuals > 0 > cash Flow > capital Expenditures
26037
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
646128
Annuals > 0 > cash Flow > net Change In Cash
643279
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.00792417926679482
Annuals > 0 > ratios > PB
52.57916287534122
Annuals > 0 > ratios > ROE
10.41616780805517
Annuals > 0 > ratios > ROA
9.95664852344047
Annuals > 0 > ratios > FCF
-2849
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
-0.0015442018985715727
Annuals > 0 > health Score
60
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
597595
Annuals > 1 > income Statement > cost Of Revenue
113188
Annuals > 1 > income Statement > gross Profit
484407
Annuals > 1 > income Statement > operating Expenses
849095
Annuals > 1 > income Statement > operating Income
-251500
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-251500
Annuals > 1 > income Statement > net Income
-251500
Annuals > 1 > income Statement > eps
-0.024598850456105725
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
10224055
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-42.08535881324308
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
19238
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
36448
Annuals > 1 > balance Sheet > inventories
37702
Annuals > 1 > balance Sheet > total Current Assets
93388
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
93388
Annuals > 1 > balance Sheet > payables
7675
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
100148
Annuals > 1 > balance Sheet > equity
-6760
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-251500
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
-56342
Annuals > 1 > cash Flow > cash From Operations
-307842
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
315511
Annuals > 1 > cash Flow > net Change In Cash
7669
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.024598850456105725
Annuals > 1 > ratios > PB
-6049.736686390532
Annuals > 1 > ratios > ROE
3720.414201183432
Annuals > 1 > ratios > ROA
-269.30654902128754
Annuals > 1 > ratios > FCF
-307842
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.5151348321187427
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
69343
Annuals > 2 > income Statement > cost Of Revenue
9699
Annuals > 2 > income Statement > gross Profit
59644
Annuals > 2 > income Statement > operating Expenses
239793
Annuals > 2 > income Statement > operating Income
-170450
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-170450
Annuals > 2 > income Statement > net Income
-170450
Annuals > 2 > income Statement > eps
-0.12483749885562574
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1365375
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-245.80707497512364
Annuals > 2 > income Statement > total Other Income Expense Net
8713
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
11569
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
7761
Annuals > 2 > balance Sheet > inventories
12278
Annuals > 2 > balance Sheet > total Current Assets
31608
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
31608
Annuals > 2 > balance Sheet > payables
3435
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
48791
Annuals > 2 > balance Sheet > equity
-17183
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-170450
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
-16604
Annuals > 2 > cash Flow > cash From Operations
-182779
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
194248
Annuals > 2 > cash Flow > net Change In Cash
11469
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.12483749885562574
Annuals > 2 > ratios > PB
-317.84321713321305
Annuals > 2 > ratios > ROE
991.9688063783973
Annuals > 2 > ratios > ROA
-539.262212098203
Annuals > 2 > ratios > FCF
-182779
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-2.6358680760855457
Annuals > 2 > health Score
31
Valuation > metrics > PE
0.04168883387504662
Valuation > metrics > PB
25.536516523990226
Valuation > final Score
40
Valuation > verdict
325.8% Overvalued
Profitability > metrics > ROE
26.61468987790029
Profitability > metrics > ROA
23.05496523651911
Profitability > metrics > Net Margin
0.2604345013237832
Profitability > final Score
100
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.19632712348712772
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
119.33595816301995
Liquidity > metrics > Quick Ratio
104.39733108920413
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
100
Prev Profitabilities > 1
8
Prev Profitabilities > 2
75
Prev Risks > 0
80
Prev Risks > 1
80
Prev Risks > 2
80
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:29:11.072Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0008
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0104
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.0097
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.0002
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0013
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.0018
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.0013
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.0009
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.0014
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.0021
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.0051
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-08-31
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.0007
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-05-31
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.0088
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-12-31
Earnings History > 13 > report Date
2022-02-28
Earnings History > 13 > date
2021-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.0032
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-06-30
Earnings History > 14 > report Date
2021-08-31
Earnings History > 14 > date
2021-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.0008
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
BioScience Health Innovations, Inc. distributes clinically tested and affordably priced products to battle the onslaught of bacteria and viruses in the United States. The company markets Be On-Guard Mouth Spray and Nasal Spray; EZ Safer Surface Cleaner; Be On-Guard brain fog support; Active Daily Health Defence 365 for maximum strength brain support; NeuroPro Plus, a patent pending combination of pharmaceutical grade methylene blue and vitamin; TBI-365 to elevate brain health and wellness with pharmaceutical grade methylene blue, glucine, nac and niacinamide; and Metabolism+ to enhance metabolism. It sells its products through Amazon platform; wholesales through online platform; private label sales; and direct sales. The company was formerly known as Nowtransit Inc and changed its name to BioScience Health Innovations, Inc. on February 21, 2025. BioScience Health Innovations, Inc. is based in Salt Lake City, Utah.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAirAsia X, Capital A, Pestech International, Globetronics, BHIC, Tenaga, TRC Synergy, Sunview, Hibiscus Petroleum KLSE Screener
Read more →BHIC considering purchase of French firm’s flood-capable motorised floating bridge system The Edge Malaysia
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of BHIC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0008
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.